Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FwN6bezIaVBBSkW0KCo1HxHjEqeg.uncropped.jpg&w=3840&q=75)
Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.0%
- Check10 days agoChange DetectedNew study details have been added, including contact information for study personnel and specific eligibility criteria for patients with newly diagnosed multiple myeloma, while several previous criteria and a serious adverse event review have been removed.SummaryDifference28%
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.0%
- Check31 days agoNo Change Detected
- Check46 days agoChange DetectedThe study has been updated to version v2.10.0, indicating a new revision from the previous version v2.9.7.SummaryDifference0.1%
- Check53 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check67 days agoChange DetectedDifference0.0%
Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.